Immediate Impact
1 by Nobel laureates 9 from Science/Nature 59 standout
Citing Papers
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Works of M. Puglisi being referenced
Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial
2017 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| M. Puglisi | 531 | 399 | 256 | 36 | 973 | |
| Mona Fouad | 629 | 273 | 154 | 32 | 879 | |
| Christopher W. Lee | 511 | 428 | 320 | 23 | 952 | |
| Gerard T. Kennealey | 394 | 559 | 206 | 26 | 1.1k | |
| Matteo Brighenti | 610 | 305 | 177 | 38 | 839 | |
| Preston D. Steen | 567 | 321 | 255 | 47 | 1.0k | |
| Ho-Yeong Lim | 342 | 301 | 295 | 31 | 850 | |
| M. Paganuzzi | 321 | 508 | 252 | 37 | 970 | |
| Casey W. Williamson | 364 | 201 | 296 | 30 | 894 | |
| Hiroki Ueda | 635 | 304 | 110 | 56 | 889 | |
| Yeu‐Tsu N. Lee | 609 | 338 | 155 | 56 | 1.0k |
All Works
Loading papers...